Nation's highest court declined to review a NJ Supreme Court decision adressing informed consent for abortion procedures.
The nation's highest court declined to review a New Jersey Supreme Court decision that addressed informed consent for abortion procedures, according to American Medical News (11/17/08).
The case began in 1998 after Rosa Acuna underwent an abortion at the advice of her physician, Dr. Sheldon C. Turkish, because the pregnancy was damaging her kidneys. Following the abortion, Ms. Acuna sued Dr. Turkish for malpractice, alleging that he failed to inform her that at the time of the abortion the embryo was a "complete, separate, unique and irreplaceable human being" and claiming that this failure had resulted in severe emotional and psychological trauma. The trial court dismissed the case, citing the US Supreme Court ruling that "a fetus is not a person," but an appellate court decided that Ms. Acuna could sue her ob/gyn for damages relating to "a question of medical malpractice."
The New Jersey Supreme Court dismissed the medical malpractice lawsuit in September 2007, however, finding that state law does not require a physician to tell a woman seeking an abortion that the procedure would result in terminating the life of a living human being. The court said that while doctors have a duty to tell patients about an abortion's medical risks, they do not have to discuss moral, religious, or philosophic judgments that lack broad support from the medical and scientific community.
Daré Bioscience initiates phase 3 clinical trial for ovaprene contraceptive
December 5th 2023Daré Bioscience has commenced a pivotal phase 3 clinical trial for ovaprene, an intravaginal contraceptive that releases a locally acting agent to prevent sperm entry into the cervical canal, marking a significant step towards a non-hormonal contraceptive option for women.
Read More
Exploring menstrual health: Insights from the Avon longitudinal study
December 5th 2023Unveiling a comprehensive analysis of menstrual cycle characteristics in mothers and daughters, this article delves into the diverse features, potential risk factors, and the importance of understanding these nuances for effective menstrual health management.
Read More
Integrating pharmacists into PPHTN management for enhanced blood pressure control
December 4th 2023A study reveals that involving pharmacists in the care of postpartum women at risk of persistently elevated blood pressure, as presented at the American Society of Health-System Pharmacists 2023 Midyear Clinical Meeting and Exhibition, can provide an effective and feasible solution to managing hypertensive disorders, reducing postpartum readmission risks, and improving overall health care access.
Read More